Johnson & Johnson
$146.489876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$146.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.63 (-0.43%) As of 1:49 PM EDT today
Why Robinhood?
You can buy or sell JNJ and other stocks, options, ETFs, and crypto commission-free!
About JNJ
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. Read More The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. The listed name for JNJ is Johnson & Johnson.
CEO
Employees
132,200
Headquarters
New Brunswick, New Jersey
Founded
1887
Market Cap
385.73B
Price-Earnings Ratio
25.60
Dividend Yield
2.69
Average Volume
6.86M
High Today
$147.92
Low Today
$146.06
Open Price
$147.60
Volume
2.78M
52 Week High
$157.00
52 Week Low
$109.16
Collections
Digestible Financial News
Jack Kramer & Nick Martell
Managing Editors of News & Snacks at Robinhood Financial LLC
JNJ News
MarketWatch21h
Johnson & Johnson stock rises Monday, still underperforms market
Shares of Johnson & Johnson JNJ, +0.99% inched 1.00% higher to $147.11 Monday, on what proved to be an all-around positive trading session for the stock market,
Analyst Ratings
71%
of 17 ratings
Buy
71%
Hold
24%
Sell
6%
JNJ Earnings
$0.00
$0.86
$1.72
$2.58
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
— per share
Actual
Available Oct 13, Pre-Market
You May Also Like
More JNJ News
ReutersSep 25
Johnson & Johnson COVID-19 vaccine produces strong immune response in early trial
(Reuters) - A single dose of Johnson & Johnson's JNJ.N experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early
MarketWatchSep 25
J&J: most Phase 1/2a participants in COVID-19 vaccine developed neutralizing antibodies
Shares of Johnson & Johnson JNJ, +0.14% were up 0.1% in trading on Friday after data from the Phase 1/2a clinical trial for its COVID-19 vaccine candidate was p
BenzingaSep 24
Current Updates On COVID-19 Vaccine
Besides saving lives and the global economy, we are expecting three things from the upcoming COVID-19 vaccine: safety, immunogenicity and efficacy. But we never
New York TimesSep 23
Your Thursday Briefing
A single-shot vaccine enters final testing in the U.S.
Johnson & Johnson has begun the final stage of clinical trials for a coronavirus vaccine that could have
BenzingaSep 23
Why Genmab's Stock Is Trading Lower Today
Genmab (NASDAQ: GMAB) shares are trading lower on Wednesday after the company announced legal arbitration with partner Johnson & Johnson (NYSE: JNJ) over Darzal
